Vaccination in a COVID-19 era
First webinar in the series: Preparing for COVID-19, RSV disease and Inlfuenza concomitant outbreaks, chaired by Ab Osterhaus and Sylvie ...
Reports
Policy & Recommendations
News
|
8th influenza conference 2021
ESWI 2021 Conference Science Policy Interface highlights
A report summarising the Science Policy Interface Track
Neutrophilic inflammation in the respiratory mucosa predisposes to RSV infection
The variable outcome of viral exposure is only partially explained by known factors. We administered respiratory syncytial virus (RSV) to 58 volunteers, of whom 57% became infected.